Trump's Surgeon General Pick Has Tobacco, Cola Stocks In Portfolio Even as Robert Kennedy Jr. Wages War On Sugary Drinks, Processed Food
Key takeaways
- Trump’s Surgeon General nominee will likely sell her tobacco, fast‑food and other holdings, potentially impacting those stocks as the administration pushes a sugary‑drink crackdown.
- Philip Morris closed 2.19% higher at $189.77
- Saphier will divest most holdings within 90 days
- Senate hearing set for Sept 16
What happened
Trump’s nominee for Surgeon General, Dr. Nicole Saphier, revealed that she owns shares in more than 200 companies, including tobacco giant Philip Morris International (PM), fast‑food and beverage firms like McDonald’s, Coca‑Cola and PepsiCo, and major tech and pharma names such as Apple, Nvidia, Meta, Amazon, Eli Lilly, Merck and UnitedHealth. She has pledged to divest from most of these holdings within 90 days of confirmation, with a few positions only partially unwound because they are held…
Why it matters
The Surgeon General’s portfolio is a high‑profile public office; any conflict of interest could undermine public trust and raise questions about the administration’s commitment to health policy. The divestiture pledge signals an attempt to pre‑empt criticism amid a broader federal push against sugary drinks and…
Short-term and longer-term
Short-term. Short‑term traders should watch the 90‑day divestment window for potential sell‑off catalysts.
Longer-term. Over the next few months, investors should assess how the divestment aligns with the Trump administration’s health policy agenda.